Tissue Elution
Tissue Elution - Related Videos
01:05
High-Performance Liquid Chromatography: Elution Process
0 Views •
2024
In High-Performance Liquid Chromatography (HPLC), the elution process is critical to the separation of analytes and the quality of chromatographic results. Elution describes how compounds move through the column and separate based on their interactions with the mobile and stationary phases. This process determines the resolution, peak shape, and retention times in the chromatogram, which are essential for identifying and quantifying components in complex mixtures. Understanding the elution...
06:18
A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
0 Views •
Cited by 5 •
2023
Here, we present a protocol to evaluate the antibacterial efficacy of an antibiotic-eluting polymer to simulate prophylactic clinical application by using a commercially available real-time ATP-based luminescent microbial viability assay. This method enables the monitoring of the longitudinal activity of drug-eluting materials and can be widely adapted to test anti-microbial drug delivery platforms.
11:38
CN-GELFrEE - Clear Native Gel-eluted Liquid Fraction Entrapment Electrophoresis
0 Views •
Cited by 11 •
2016
This protocol describes how to prepare and perform clear native gel-eluted liquid fraction entrapment electrophoresis (CN-GELFrEE), a native separation technique for non-covalent biomolecular assemblies and proteins from heterogeneous samples that is compatible with various downstream protein analysis techniques.
08:26
Design of a Biocompatible Drug-Eluting Tracheal Stent in Mice with Laryngotracheal Stenosis
0 Views •
Cited by 13 •
2020
Laryngotracheal stenosis results from pathologic scar deposition that critically narrows the tracheal airway and lacks effective medical therapies. Using a PLLA-PCL (70% poly-L-lactide and 30% polycaprolactone) stent as a local drug delivery system, potential therapies aimed at decreasing scar proliferation in the trachea can be studied.
03:41
DFE-Based Affinity Chromatography: A Technique for Purification of 2F5 Monoclonal Antibodies from a Crude Sample Using High Ionic Strength-Based Elution Conditions
0 Views •
2025
This video describes an affinity chromatography technique for purifying 2F5 monoclonal antibodies using the DsRed-2F5-Epitope or DFE ligands. The purified 2F5 monoclonal antibodies are essential drugs in immunotherapy.
FAQs
The extraction buffer provides the liquid environment into which soluble tissue-associated molecules can move, while mixing promotes contact between the tissue and fluid. During incubation, proteins, cytokines, and other soluble mediators diffuse into the buffer. These conditions make the recovered eluate suitable for downstream biochemical assays and help produce a measurable representation of soluble signals in the specimen.
Sectioning or mincing changes how the tissue is presented to the extraction buffer. These preparation choices allow the buffer to contact the specimen before incubation and mixing, supporting transfer of soluble components into the liquid phase. The resulting extract can therefore be prepared from tissue in a form that is practical for subsequent molecular measurements.
Centrifugation separates the liquid eluate from cellular debris after extraction. This clarification step helps distinguish the solution containing recovered soluble molecules from remaining tissue material, producing a more suitable sample for analysis. It is especially useful when the goal is to measure proteins, cytokines, or other soluble mediators rather than analyze intact or particulate tissue.
A typical workflow begins by sectioning or mincing the biological tissue and placing it in an extraction buffer. The sample is then incubated with mixing so soluble components enter the fluid. After incubation, centrifugation can separate the eluate from debris. The recovered solution is subsequently used for biochemical assays or other quantitative analyses.
The eluate can contain proteins, cytokines, and other soluble mediators associated with the tissue. Measuring these components helps characterize molecular signals within the tumor microenvironment and supports biomarker analysis. Because the signals are transferred into a liquid sample, researchers can examine them using downstream biochemical assays rather than relying only on the original tissue material.
Extracts prepared from different specimens can be analyzed for differences in soluble molecular signals. In cancer research, these measurements help characterize the tumor microenvironment and assess treatment-related changes across samples. Comparing the resulting biochemical data can therefore support quantitative studies of cancer biology and reveal how specimens differ in their measured protein, cytokine, or mediator profiles.